MUSCAT: An International Medical Conference on Deep Brain Stimulation (DBS) was held in Muscat on July 26, bringing together ...

Learn about the disease mechanisms and latest advancements in Parkinson's treatment.

Groundbreaking research by the University of Sydney has identified a new brain protein involved in the development of Parkinson's disease and a way to modify it, paving the way for future ...

Rasagiline: A Second-Generation Monoamine Oxidase Type-B Inhibitor for the Treatment of Parkinson's Disease Jack J. Chen; Anh-Vuong Ly Disclosures Am J Health Syst Pharm. 2006;63 (10):915-928.

Students and staff at the University of Wisconsin-Eau Claire are working on vibrating gloves to reduce symptoms of Parkinson’s disease.

Regular consumption has been linked to improved mood and cognitive performance, potentially reducing the risk of neurodegenerative diseases such as Alzheimer's and Parkinson's ... skin healing and may ...

Most Parkinson's symptoms stem from the loss or dysfunction of dopamine-producing neurons in a brain region involved in fine motor control, called the substantia nigra. This is thought to be ...

Brett Favre Turns to a Controversial Treatment for Parkinson's Disease originally appeared on Men's Fitness. In September, Favre revealed his diagnosis with Parkinson's disease.

Parkinson’s disease affects more than 10 million people worldwide. Discover its causes, symptoms, and the latest innovations in diagnosis and treatment.

About Parkinson’s disease associated with GBA mutations (PD-GBA) Mutations in GBA, the gene expressing the GCase enzyme, affect up to 15% of Parkinson’s patients and are the most common ...

By Dean Seal Acadia Pharmaceuticals has scored a second court win in less than a month that protects patents for its Parkinson's Disease treatment Nuplazid.